RSS

small molecules

UK based fund manager, Sixth Element Capital, has announced a £3 million investment in a spin out company from PhoreMost — NeoPhore. more

News

A research collaboration between Axxam and Sanofi has been announced, which will be aimed at further optimising several small molecules targeted against a range of diseases of the central nervous system (CNS). more

News

Cambrex, manufacturer of small molecule active pharmaceutical ingredients (APIs), has announced it is investing in new capacity and continuous flow technology at its Karlskoga facility in Sweden. more

News

Cresset, a provider of software and contract research services for small molecule discovery and design, has signed a three-way strategic agreement to speed up drug design. more

News

Phylogica has entered into an agreement with PhoreMost, a biotechnology company, to identify and develop small molecule cancer drugs. more

News

LGC and Quotient Bioresearch are pleased to announce that they have reached agreement on the sale by Quotient of its Bioanalytical Sciences division to LGC. more

Technology